olmesartan medoxomil
UkraineDrugs containing this active substance
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg amlodipine 5 mg hydrochlorothiazide 12.5 mg ATC: C09DX03
Manufacturer: Daichi Sankyo Europe GmbH (manufacturing "in bulk", packaging, control and batch release)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 10 mg hydrochlorothiazide 12.5 mg ATC: C09DX03
Manufacturer: Daichi Sankyo Europe GmbH (manufacturing "in bulk", packaging, control and batch release)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 10 mg hydrochlorothiazide 25 mg ATC: C09DX03
Manufacturer: Daichi Sankyo Europe GmbH (manufacturing "in bulk", packaging, control and batch release)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults who fail to achieve adequate blood pressure control using only one component (olmesartan or amlodipine).
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg amlodipine 5 mg ATC: C09DB02
Manufacturer: Daichi Sankyo Europe GmbH (manufacturing in bulk, quality control and batch release)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults who fail to achieve adequate blood pressure control using only one component (olmesartan or amlodipine).
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 10 mg ATC: C09DB02
Manufacturer: Daichi Sankyo Europe GmbH (manufacturing in bulk, quality control and batch release)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adult patients who fail to achieve adequate blood pressure control using only one component (olmesartan or amlodipine).
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 5 mg ATC: C09DB02
Manufacturer: Daichi Sankyo Europe GmbH (manufacturing in bulk, quality control and batch release)
-
The drug is intended for the treatment of arterial hypertension (high blood pressure) in adults, as well as in children and adolescents aged 6 to 18 years.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 10 mg ATC: C09CA08
Manufacturer: Daiichi Sankio Europe GmbH (manufacturing "in bulk", primary and secondary packaging, quality control and batch release)
-
The drug is intended for the treatment of arterial hypertension (high blood pressure) in adults, as well as in children and adolescents aged 6 to 18 years.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg ATC: C09CA08
Manufacturer: Daiichi Sankio Europe GmbH (manufacturing "in bulk", primary and secondary packaging, quality control and batch release)
-
The drug is intended for the treatment of arterial hypertension (high blood pressure) in adults, as well as in children and adolescents aged 6 to 18 years.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg ATC: C09CA08
Manufacturer: Daiichi Sankio Europe GmbH (manufacturing "in bulk", primary and secondary packaging, quality control and batch release)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults for whom taking a single component (olmesartan medoxomil) alone is insufficient to achieve the required blood pressure level.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 12.5 mg ATC: C09DA08
Manufacturer: Daiichi Sankyo Europe GmbH (manufacturing in bulk)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults for whom monotherapy (olmesartan medoxomil) is insufficient to achieve the required blood pressure level.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 25 mg ATC: C09DA08
Manufacturer: Daiichi Sankyo Europe GmbH (manufacturing in bulk)
-
These medications are prescribed for the treatment of essential arterial hypertension (high blood pressure).
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg ATC: C09CA08
Manufacturer: Alembic Pharmaceuticals Limited
-
These medications are prescribed for the treatment of essential arterial hypertension (high blood pressure).
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg ATC: C09CA08
Manufacturer: Alembic Pharmaceuticals Limited
-
These medications are prescribed for the treatment of essential hypertension (high blood pressure) in adults who do not achieve adequate control with a single component (olmesartan medoxomil) alone.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 12.5 mg ATC: C09DA08
Manufacturer: Alembic Pharmaceuticals Limited
-
These medications are prescribed for the treatment of essential hypertension (high blood pressure) in adults for whom monotherapy (olmesartan medoxomil) is insufficient.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg hydrochlorothiazide 12.5 mg ATC: C09DA08
Manufacturer: Alembic Pharmaceuticals Limited
-
The drug is intended for the treatment of arterial hypertension (high blood pressure) in adults, as well as in children and adolescents aged 6 to 18 years.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 10 mg ATC: C09CA08
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is used to treat arterial hypertension (high blood pressure) in adults, as well as in children and adolescents aged 6 to 18 years.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg ATC: C09CA08
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is intended for the treatment of arterial hypertension (high blood pressure) in adults, as well as in children and adolescents aged 6 to 18 years.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg ATC: C09CA08
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure). It is used in cases where taking a single component (olmesartan or amlodipine) does not allow for achieving the necessary blood pressure control.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg amlodipine 5 mg ATC: C09DB02
Manufacturer: Hemofarm AD (manufacturing of unpackaged product, primary and secondary packaging, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure), especially in cases where the use of a single component does not provide the desired result.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 10 mg ATC: C09DB02
Manufacturer: Hemofarm AD (manufacturing of unpackaged product, primary and secondary packaging, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults who do not achieve sufficient control with olmesartan medoxomil alone.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 12.5 mg ATC: C09DA08
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults for whom treatment with a single component (olmesartan medoxomil) alone is insufficient.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 25 mg ATC: C09DA08
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults for whom taking a single component (olmesartan medoxomil) alone is insufficient to achieve the required blood pressure level.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg hydrochlorothiazide 12.5 mg ATC: C09DA08
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults for whom treatment with a single component (olmesartan medoxomil) alone is insufficient.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg hydrochlorothiazide 25 mg ATC: C09DA08
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure). It may also be used as add-on therapy if other drug combinations do not provide adequate blood pressure control, or as a replacement for other agents.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg amlodipine 5 mg hydrochlorothiazide 12.5 mg ATC: C09DX03
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure). It may also be used as add-on therapy if other combination agents do not provide adequate blood pressure control, or as a replacement for other medications.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 10 mg hydrochlorothiazide 12.5 mg ATC: C09DX03
Manufacturer: STADA Arzneimittel AG (batch release, batch control)
-
The drug is used to treat essential hypertension (high blood pressure) in adults, as well as hypertension in children and adolescents aged 6 to 18 years.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 10 mg ATC: C09CA08
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults, as well as hypertension in children and adolescents aged 6 to 18 years.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg ATC: C09CA08
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults, as well as hypertension in children and adolescents aged 6 to 18 years.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg ATC: C09CA08
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for the treatment of essential hypertension (high blood pressure). It is used in cases where taking a single component (olmesartan or amlodipine) does not allow for achieving the necessary blood pressure control.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg amlodipine 5 mg ATC: C09DB02
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for the treatment of essential hypertension (high blood pressure). It is used in cases where the administration of individual components (olmesartan or amlodipine) does not allow for achieving the necessary blood pressure control.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 10 mg ATC: C09DB02
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for the treatment of essential hypertension (high blood pressure). It is used in cases where treatment with individual active substances does not provide adequate blood pressure control.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 5 mg ATC: C09DB02
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for the treatment of essential hypertension (high blood pressure).
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 10 mg hydrochlorothiazide 12.5 mg ATC: C09DX03
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for the treatment of essential hypertension (high blood pressure).
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 5 mg hydrochlorothiazide 12.5 mg ATC: C09DX03
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is prescribed for the treatment of essential hypertension (high blood pressure) in adults, as well as for the treatment of hypertension in children and adolescents aged 6 to 18 years.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 10 mg ATC: C09CA08
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for the treatment of high blood pressure (essential hypertension) in adults, as well as for the treatment of hypertension in children and adolescents aged 6 to 18 years.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg ATC: C09CA08
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is used to treat essential hypertension (high blood pressure) in adults, as well as to treat hypertension in children and adolescents aged 6 to 18 years.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg ATC: C09CA08
Manufacturer: Macleods Pharmaceuticals Limited
-
The drug is intended for adults with essential hypertension (high blood pressure) if the use of a single component (olmesartan medoxomil) alone is insufficient to achieve the desired blood pressure level.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 12.5 mg ATC: C09DA08
Manufacturer: Daiichi Sankyo Europe GmbH
-
The drug is intended for adults with essential hypertension (high blood pressure) if the use of a single component (olmesartan medoxomil) alone is insufficient to achieve the required blood pressure level.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 25 mg ATC: C09DA08
Manufacturer: Daiichi Sankyo Europe GmbH
-
The drug is intended for adults with essential hypertension (high blood pressure) for whom the use of a single component (olmesartan) alone does not achieve the required blood pressure level.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg hydrochlorothiazide 12.5 mg ATC: C09DA08
Manufacturer: Daiichi Sankyo Europe GmbH
-
The drug is intended for adults with essential hypertension (high blood pressure) if the use of a single component (olmesartan medoxomil) alone is insufficient to achieve the required blood pressure level.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg hydrochlorothiazide 25 mg ATC: C09DA08
Manufacturer: Daiichi Sankyo Europe GmbH
-
The drug is intended for the treatment of arterial hypertension (high blood pressure) in adults, as well as in children and adolescents aged 6 to 18 years.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg ATC: C09CA08
Manufacturer: JSC "Kyiv Vitamin Plant"
-
The drug is intended for the treatment of arterial hypertension (high blood pressure) in adults, as well as in children and adolescents aged 6 to 18 years.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg ATC: C09CA08
Manufacturer: JSC "Kyiv Vitamin Plant"
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults for whom monotherapy (olmesartan medoxomil) is insufficient.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg hydrochlorothiazide 12.5 mg ATC: C09DA08
Manufacturer: JSC "Kyiv Vitamin Plant"
-
The drug is intended for the treatment of essential hypertension (high blood pressure). It is used in cases where the use of a single component (olmesartan medoxomil or amlodipine) does not allow for achieving the necessary blood pressure control.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg amlodipine 5 mg ATC: C09DB02
Manufacturer: Genpharm S.A. (manufacturing 'in bulk', primary and secondary packaging, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure), especially in cases where the use of a single component (olmesartan or amlodipine) does not provide sufficient results.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 5 mg ATC: C09DB02
Manufacturer: Genpharm S.A. (manufacturing 'in bulk', primary and secondary packaging, batch control)
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults for whom monotherapy is insufficient.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg amlodipine 5 mg ATC: C09DB02
Manufacturer: Daiichi Sankyo Europe GmbH
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults for whom monotherapy (with olmesartan or amlodipine) is insufficient.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 5 mg ATC: C09DB02
Manufacturer: Daiichi Sankyo Europe GmbH
-
The drug is intended for the treatment of essential hypertension (high blood pressure) in adults for whom monotherapy is insufficient.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 40 mg amlodipine 10 mg ATC: C09DB02
Manufacturer: Daiichi Sankyo Europe GmbH
-
The drug is intended for the treatment of essential hypertension (high blood pressure). It may also be used as add-on therapy if other drug combinations do not provide adequate blood pressure control, or as a replacement for other agents.
Form: tablets, film-coated
Active substance Dosage olmesartan medoxomil 20 mg amlodipine 5 mg hydrochlorothiazide 12.5 mg ATC: C09DX03
Manufacturer: Daiichi Sankyo Europe GmbH